Henry Schein, Inc. HSIC
NASDAQ · Healthcare · Medical - Distribution
$83.52
Close on Fri, 20 Nov 2026 · market value $9.2B
What the price is betting on
Below its recordAt $84, the price assumes revenue grows about 2.4% a year for five years, from $13.7B to about $15.2B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8.5% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than HSIC? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$84
Base
$94
Bull
$105
Today $84
- Bear $84. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $94. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $105. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$13.8B$13.8B, on the path
- FY2027$14.1B$14.4B, on the path
- FY2028$14.5B$14.9B, on the path
- FY2029$14.8B$15.9B, on the path
- FY2030$15.2BThe full bet
Each year's revenue at 2.4% growth from $13.7B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Distribution · listed on NASDAQ
- Revenue, FY2025
- $13.2B
- Growth, 3 years a year
- 4%
- Cash margin
- 4.3%
- Net debt
- $3.5B
- Shares, 3-year change
- −14%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.